Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Cipla
Healthtrust
McKesson
UBS
US Army
Express Scripts
Citi

Generated: June 23, 2018

DrugPatentWatch Database Preview

CHLOROTHIAZIDE AND RESERPINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Chlorothiazide And Reserpine patents expire, and when can generic versions of Chlorothiazide And Reserpine launch?

Chlorothiazide And Reserpine is a drug marketed by Hikma Pharms and is included in two NDAs.

The generic ingredient in CHLOROTHIAZIDE AND RESERPINE is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
Summary for CHLOROTHIAZIDE AND RESERPINE
Drug patent expirations by year for CHLOROTHIAZIDE AND RESERPINE
Synonyms for CHLOROTHIAZIDE AND RESERPINE
8055-35-4
C33H40N2O9.C7H6ClN3O4S2
Chlorothiazide mixture with Reserpine
CHLOROTHIAZIDE W/ RESERPINE
CHLOROTHIAZIDE-RESERPINE
CHLOROTHIAZIDE; RESERPINE
DTXSID40230389
LS-178508
SCHEMBL4058999

US Patents and Regulatory Information for CHLOROTHIAZIDE AND RESERPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms CHLOROTHIAZIDE AND RESERPINE chlorothiazide; reserpine TABLET;ORAL 088557-001 Dec 22, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Pharms CHLOROTHIAZIDE AND RESERPINE chlorothiazide; reserpine TABLET;ORAL 088365-001 Dec 22, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Baxter
Argus Health
US Army
Harvard Business School
AstraZeneca
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.